Case Report

18F-FDG PET/CT Findings of a Patient with Wegener’s Granulomatosis Before and After Therapy
  • Elif Özdemir
  • Nilüfer Yildirim Poyraz
  • Aysegül Sentürk
  • Ebru Uz
  • Mutlay Keskin
  • Levent Yüksel
  • Zuhal Kandemir
  • Seyda Türkölmez
Mol Imaging Radionucl Ther 2015; 24: 1-3 DOI: 10.4274/mirt.02886
Diagnosis of Brachiocephalic Thrombophlebitis as the Cause of Fever of Unknown Origin by 18F-FDG-PET/CT
  • Anastas Demirev
  • Boudewijn Brans
  • Floris Vanmolkot
  • Rick De Graaf
  • Felix Mottaghy
  • Jan Bucerius
Mol Imaging Radionucl Ther 2015; 24: 25-28 DOI: 10.4274/mirt.47966 PMID:25800595
Changes in 18F-FDG PET-CT Appearances of Treated Malignant Melanoma Metastases within the Right Atrium
  • Luke Ienari Sonoda
  • Bal Sanghera
  • Katharine Nowlan
  • Emma Roantree
  • Thomas Wagner
  • Paul Nathan
Mol Imaging Radionucl Ther 2015; 24: 25-27 DOI: 10.4274/mirt.47955
18F-FDG PET-CT for Evaluation of Cardiac Angiosarcoma: A Case Report and Review of Literature
  • Varun Singh Dhull
  • Punit Sharma
  • Anirban Mukherjee
  • Manisha Jana
  • Chandrasekhar Bal
  • Rakesh Kumar
Mol Imaging Radionucl Ther 2015; 24: 32-36 DOI: 10.4274/mirt.02486 PMID:25800597
Extrapulmonary Small Cell Carcinoma of the Seminal Vesicles and Prostate Demonstrated on 18F-FDG Positron Emission Tomography/Computed Tomography
  • Amir Iravani Tabrizipour
  • Lily Shen
  • Robert Mansberg
  • Bui Chuong
Mol Imaging Radionucl Ther 2016; 25: 47-49 DOI: 10.4274/mirt.02997 PMID:27299289
Schwannomatozis of the Chest Wall: FDG PET Findings
  • Seyfettin Ilgan
  • Erkan Dikmen
  • Cihan Genco Çetinkanat
  • Mehmet Dakak
  • Adem Güngör
Mol Imaging Radionucl Ther 2014; 23: 64-66 DOI: 10.4274/mirt.353 PMID:24963448
Detection of Hodgkin Transformation in a Case of Chronic Lymphocytic Leukemia by PET/CT
  • Sabire Yılmaz
  • Meftune Özhan
  • Sertaç Asa
  • M. Sait Sağer
  • Fatih Selçuk Biricik
  • Metin Halaç
  • Kerim Sönmezoğlu
Mol Imaging Radionucl Ther 2014; 23: 67-69 DOI: 10.4274/mirt.362 PMID:24963449
FDG PET-CT Finding in Bilateral Renal and Bone Involvement of Diffuse Large B-Cell Lymphoma
  • Yusuf Ziya Tan
  • Sabire Yılmaz
  • Meftune Özhan
  • Metin Halaç
Mol Imaging Radionucl Ther 2014; 23: 104-106 DOI: 10.4274/mirt.98608 PMID:25541935
18F-NaF Positive Bone Metastases of Non 18F-FDG Avid Mucinous Gastric Cancer
  • Çiğdem Soydal
  • Elgin Özkan
  • Özlem Nuriye Küçük
  • Metin Kemal Kır
Mol Imaging Radionucl Ther 2015; 24: 132-134 DOI: 10.4274/mirt.92400 PMID:27529889

Original Article

The Role of 18F-FDG PET/CT in Evaluating Elevated Levels of Tumor Markers in Breast Cancer
  • İnan Göktaş
  • Hakan Cayvarlı
Mol Imaging Radionucl Ther 2018; 27: 3-9 DOI: 10.4274/mirt.74436 PMID:29393047
Contribution of 18F-FDG PET/CT to Staging of Head and Neck Malignancies
  • Yeşim Ceylan
  • Özgür Ömür
  • Filiz Hatipoğlu
Mol Imaging Radionucl Ther 2018; 27: 19-24 DOI: 10.4274/mirt.51423 PMID:29393049
Uptake Patterns of Untreated Primary Gastrointestinal Extranodal Lymphomas on Initial Staging 18F-FDG PET/CT and Metabolic Tumor Parameters
  • Engin Alagöz
  • Kürsat Okuyucu
  • Semra Ince
  • Murat Kantarcioglu
  • Sükrü Özaydin
  • Cumhur Heper
  • Türker Türker
  • Nuri Arslan
Mol Imaging Radionucl Ther 2017; 26: 83-92 DOI: 10.4274/mirt.48658 PMID:28976330
Thyroid Incidentalomas on 18F-FDG PET/CT: Clinical Significance and Controversies
  • William Makis
  • Anthony Ciarallo
Mol Imaging Radionucl Ther 2017; 26: 93-100 DOI: 10.4274/mirt.94695 PMID:28976331

Original Research

Adding 11C-acetate to 18F-FDG at PET Examination Has an Incremental Value in the Diagnosis of Hepatocellular Carcinoma
  • Patricia Larsson
  • Dag Arvidsson
  • Mikael Björnstedt
  • Bengt Isaksson
  • Ulf Jersenius
  • Hooman Motarjemi
  • Hans Jacobsson
Mol Imaging Radionucl Ther 2012; 21: 6-12 DOI: 10.4274/Mirt.87 PMID:23487415
Prognostic Value of Metabolic Tumor Volume Measured by 18F-FDG PET/CT in Esophageal Cancer Patients
  • Çiğdem Soydal
  • Cabir Yüksel
  • Nuriye Özlem Küçük
  • İlker Ökten
  • Elgin Özkan
  • Beyza Doğanay Erdoğan
Mol Imaging Radionucl Ther 2014; 23: 12-15 DOI: 10.4274/Mirt.07379 PMID:24653929
The Role of 18F-FDG PET/CT in the Primary Staging of Gastric Cancer
  • Mustafa Filik
  • Kemal Metin Kir
  • Bülent Aksel
  • Çiğdem Soydal
  • Elgin Özkan
  • Özlem Nuriye Küçük
  • Erkan İbiş
  • Hikmet Akgül
Mol Imaging Radionucl Ther 2015; 24: 15-20 DOI: 10.4274/mirt.26349 PMID:25800593
18F-FLT Positron Emission Tomography/Computed Tomography Imaging in Pancreatic Cancer: Determination of Tumor Proliferative Activity and Comparison with Glycolytic Activity as Measured by 18F-FDG Positron Emission Tomography/Computed Tomography Imaging
  • Senait Aknaw Debebe
  • Mohammed Goryawala
  • Malek Adjouadi
  • Anthony J. Mcgoron
  • Seza A. Güleç
Mol Imaging Radionucl Ther 2016; 25: 32-38 DOI: 10.4274/mirt.24008 PMID:27299286
Proliferative and Glycolytic Assessment of the Whole-Body Bone Marrow Compartment
  • Mohammed Goryawala
  • Malek Adjoua
  • Seza Güleç
Mol Imaging Radionucl Ther 2015; 24: 71-79 DOI: 10.4274/mirt.22931 PMID:26316472
The Role of 18F-FDG PET/CT in the Evaluation of Gastric Cancer Recurrence
  • Hakan Cayvarlı
  • Recep Bekiş
  • Tülay Akman
  • Deniz Altun
Mol Imaging Radionucl Ther 2014; 23: 76-83 DOI: 10.4274/mirt.83803 PMID:25541930

Original Article

The Role of 18F-FDG PET/CT in Detecting Ovarian Cancer Recurrence in Patients with Elevated CA-125 Levels
  • Arzu Cengiz
  • Zehra Pınar Koç
  • Pelin Özcan Kara
  • Yakup Yürekli
Mol Imaging Radionucl Ther 2019; 28: 8-14 DOI: 10.4274/mirt.galenos.2018.00710 PMID:30942056
The Added-value of Staging 18F-FDG PET/CT in the Prediction of Overall Survival in the Patients with Bladder Cancer
  • Seda Gülbahar Ateş
  • Bedriye Büşra Demirel
  • Halil Başar
  • Gülin Uçmak
Mol Imaging Radionucl Ther 2024; 33: 11-18 DOI: 10.4274/mirt.galenos.2023.65002 PMID:38390706
Axillary Lymph Node Uptake on 18F-FDG PET/CT after COVID-19 Vaccination: A Direct Comparison Study with Influenza Vaccination
  • Yoichi Otomi
  • Takayoshi Shinya
  • Hiroto Kasai
  • Naoko Okada
  • Tomoki Matsushita
  • Kohei Higashi
  • Saya Matsuzaki
  • Yuka Hiroshima
  • Michiko Kubo
  • Hideki Otsuka
  • Masafumi Harada
Mol Imaging Radionucl Ther 2023; 32: 13-19 DOI: 10.4274/mirt.galenos.2022.27136 PMID:36817634
The Evaluation of Preoperative 18F-FDG PET/CT in Patients with Endometrial Cancer and the Correlation Between PET Parameters and Postoperative Pathology Results
  • Özge Vural Topuz
  • Ayşegül Aksu
  • Sadife Rüya Erinç
  • Nedim Tokgözoğlu
  • Müge Öner Tamam
Mol Imaging Radionucl Ther 2022; 31: 16-22 DOI: 10.4274/mirt.galenos.2021.33154 PMID:35114747
18Fluorine-fluorodeoxyglucose PET/CT Imaging in Childhood Malignancies
  • Nilüfer Bıçakçı
  • Murat Elli
Mol Imaging Radionucl Ther 2021; 30: 18-27 DOI: 10.4274/mirt.galenos.2020.64436 PMID:33586403
Investigation of Added Value of Imaging Performed in a Prone Position to Standard 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging for Staging in Patients with Breast Cancer
  • Ezgi Başak Erdoğan
  • Mehmet Aydın
Mol Imaging Radionucl Ther 2022; 31: 23-32 DOI: 10.4274/mirt.galenos.2021.48343 PMID:35114748
18F-FDG-PET/CT in Initiation and Progression of Inflammation and Infection
  • Türkan Ertay
  • Mine Sencan Eren
  • Meral Karaman
  • Gülgün Oktay
  • Hatice Durak
Mol Imaging Radionucl Ther 2017; 26: 47-52 DOI: 10.4274/mirt.18291 PMID:28613196
The Impact of Primary Tumor and Locoregional Metastatic Lymph Node SUVmax on Predicting Survival in Patients with Rectal Cancer
  • Göksel Alçın
  • Yasemin Şanlı
  • Gülçin Yeğen
  • Esra Kaytan Sağlam
  • Tevfik Fikret Çermik
Mol Imaging Radionucl Ther 2020; 29: 65-71 DOI: 10.4274/mirt.galenos.2020.40316 PMID:32368877
Usefulness of 18F-FDG PET/CT in Cutaneous Melanoma Patients with Negative Sentinel Lymph Nodes and High Clark Levels
  • Özge Vural Topuz
  • Fatma Arzu Görtan
  • Zübeyde Rana Kaya Döner
  • Çetin Önsel
  • Haluk Burçak Sayman
Mol Imaging Radionucl Ther 2018; 27: 66-72 DOI: 10.4274/mirt.70783 PMID:29889028
68Ga-PSMA PET/CT Versus 18F-FDG PET/CT for Imaging of Hepatocellular Carcinoma
  • Cihan Gündoğan
  • Nurhan Ergül
  • Mehmet Semih Çakır
  • Özgür Kılıçkesmez
  • Rıza Umar Gürsu
  • Tamer Aksoy
  • Tevfik Fikret Çermik
Mol Imaging Radionucl Ther 2021; 30: 79-85 DOI: 10.4274/mirt.galenos.2021.92053 PMID:34082503
The Role of Metabolic Volumetric Parameters in Predicting Malignancy in Incidental Thyroid Nodules Detected in 18F-FDG PET/CT Scans
  • Mehmet Erdoğan
  • Hakan Korkmaz
  • Bora Torus
  • Mustafa Avcı
  • Şerife Mehtap Boylubay
  • Metin Çiriş
  • Mustafa Yıldız
  • Sevim Süreyya Şengül
Mol Imaging Radionucl Ther 2021; 30: 86-92 DOI: 10.4274/mirt.galenos.2021.75983 PMID:34082507
Correlation of 18F-FDG/PET SUVmax, SUVmean, MTV, and TLG with HIF-1α in Patients with Colorectal Cancer
  • Zümrüt Arda Kaymak
  • Nermin Karahan
  • Mehmet Erdoğan
  • Evrim Erdemoğlu
  • İsmail Zihni
  • Sevim Süreyya Şengül
Mol Imaging Radionucl Ther 2021; 30: 93-100 DOI: 10.4274/mirt.galenos.2021.04934 PMID:34082509
Prevalence and Clinical Significance of Incidental Focal 18F-FDG Uptake in Colon on PET/CT Imaging
  • Yasemin Gökden
  • Filiz Özülker
  • Tamer Özülker
Mol Imaging Radionucl Ther 2022; 31: 96-103 DOI: 10.4274/mirt.galenos.2022.38247 PMID:35770960
Contribution of 18F-FDG PET/CT in the Differential Diagnosis of Pulmonary Hamartomas and Pulmonary Carcinoids
  • Ebru Tatcı
  • Özlem Özmen
  • Ayperi Öztürk
  • Funda Demirağ
Mol Imaging Radionucl Ther 2021; 30: 101-106 DOI: 10.4274/mirt.galenos.2021.20633 PMID:34082511
The Prognostic Value of 18F-FDG PET/CT Metabolic Parameters in Predicting Treatment Response Before EGFR TKI Treatment in Patients with Advanced Lung Adenocarcinoma
  • Nurşin Agüloğlu
  • Murat Akyol
  • Halil Kömek
  • Nuran Katgı
Mol Imaging Radionucl Ther 2022; 31: 104-113 DOI: 10.4274/mirt.galenos.2022.24650 PMID:35770976
Metabolic Characterization of Anterior Mediastinal Masses by 18F-FDG PET/CT
  • Zehra Pınar Koç
  • Pınar Pelin Özcan
  • Erhan Ayan
  • Rabia Bozdoğan Arpacı
Mol Imaging Radionucl Ther 2020; 29: 105-111 DOI: 10.4274/mirt.galenos.2020.05657 PMID:33094573
18F-FDG PET/CT in Patients with Parenchymal Changes Attributed to Radiation Pneumonitis
  • Anastas Krassenov Demirev
  • Irena Dimitrova Kostadinova
  • Iliya Rumenov Gabrovski
Mol Imaging Radionucl Ther 2018; 27: 107-112 DOI: 10.4274/mirt.55706 PMID:30317847
The Use of 18F-FDG PET/CT in Patients with Recurrent Differentiated Thyroid Cancer
  • Özgül Ekmekçioğlu
Mol Imaging Radionucl Ther 2021; 30: 137-143 DOI: 10.4274/mirt.galenos.2021.02360 PMID:34658228
The Relationship Between HER-2 Expression Levels and 18F-FDG PET/CT Parameters in Gastric Cancer
  • Seyit Ahmet Ertürk
  • Zekiye Hasbek
  • Hatice Özer
Mol Imaging Radionucl Ther 2021; 30: 150-157 DOI: 10.4274/mirt.galenos.2021.78055 PMID:34658230
Prognostic Prediction of BRCA Mutations by 18F-FDG PET/CT SUVmax in Breast Cancer
  • Semra Özdemir
  • Fatma Sılan
  • Mehmet Yılmaz Akgün
  • Nilgün Aracı
  • İsmail Çırpan
  • Fulya Koç Öztürk
  • Öztürk Özdemir
Mol Imaging Radionucl Ther 2021; 30: 158-168 DOI: 10.4274/mirt.galenos.2021.82584 PMID:34658299
Contribution of Open Mouth Technique in 18F-FDG PET/CT Imaging in Patients with Malignant Lip Neoplasm
  • Gözde Mütevelizade
  • Ceren Sezgin
  • Yasemin Parlak
  • Gül Gümüşer
  • Elvan Sayit
Mol Imaging Radionucl Ther 2022; 31: 172-178 DOI: 10.4274/mirt.galenos.2022.79836 PMID:36268853
The Effects of CoronaVac (Sinovac) and BNT162b2 (BioNTech/Pfizer) Vaccination on Oncologic 18F-FDG PET/CT Studies
  • Hüseyin Şan
  • Engin Alagöz
Mol Imaging Radionucl Ther 2022; 31: 179-190 DOI: 10.4274/mirt.galenos.2022.86570 PMID:36268854
Relationship Between Metabolic Activity, Cellularity, Histopathological Features of Primary Tumors and Distant Metastatic Potential in Breast Cancer
  • Uğuray Aydos
  • Seda Gülbahar Ateş
  • Osman Kurukahvecioğlu
  • Ümit Özgür Akdemir
  • Pınar Uyar Göçün
  • Lütfiye Özlem Atay
Mol Imaging Radionucl Ther 2023; 32: 195-205 DOI: 10.4274/mirt.galenos.2022.60024 PMID:37870280
Volumetric Evaluation of Staging 18F-FDG PET/CT Images in Patients with Esophageal Cancer
  • Nazlı Pınar Karahan Şen
  • Ayşegül Aksu
  • Gamze Çapa Kaya
Mol Imaging Radionucl Ther 2022; 31: 216-222 DOI: 10.4274/mirt.galenos.2022.38980 PMID:36268888
Investigation of Clinical Histopathologic Features and Metabolic Parameters of 18F-FDG PET/CT in Invasive Breast Carcinoma with a Micropapillary Component
  • Elife Akgün
  • Göksel Alçın
  • Esra Canan Kelten Talu
  • Tevfik Fikret Çermik
  • Tuçe Söylemez Akkurt
  • Ebru Şen
  • Esra Arslan
Mol Imaging Radionucl Ther 2023; 32: 221-225 DOI: 10.4274/mirt.galenos.2023.06078 PMID:37870289

Case Report

18F-FDG Positron Emission Tomography/Computed Tomography in the Diagnosis and Post-Therapeutic Treatment in a Patient with an Early Stage of Retroperitoneal Fibrosis
  • Artor Niccoli Asabella
  • A. Nicoletti
  • C. Altini
  • A. Notaristefano
  • G. Lastilla
  • G. Rubini
Mol Imaging Radionucl Ther 2013; 22: 60-62 DOI: 10.4274/Mirt.140 PMID:24003399
FDG Uptake Pattern on PET/CT Imaging in Non-Infectious Graft of a Patient with Operated Abdominal Aortic Aneurysm
  • Pelin Özcan Kara
  • Gonca Kara Gedik
  • Taylan Kara
  • Ismail Koçak
  • Erhan Varoglu
  • Oktay Sari
Mol Imaging Radionucl Ther 2012; 21: 110-113 DOI: 10.4274/Mirt.98 PMID:23486376
Rare case of Primary Pulmonary Extranodal Non-Hodgkin’s Lymphoma in a Patient with Sjogrens Syndrome: Role of FDG-PET/CT in the Initial Staging and Evaluating Response to Treatment
  • Gonca G. Bural
  • Judith Joyce
  • James Ohr
Mol Imaging Radionucl Ther 2012; 21: 117-120 DOI: 10.4274/Mirt.76 PMID:23487490